Ally Bridge Group is a global healthcare investment firm that specializes in providing strategic funding and guidance to innovative companies in the life sciences and healthcare sectors. The firm focuses on creating value for its portfolio companies through its extensive network, deep industry expertise, and collaborative approach to investments.

Ally Bridge Group is a global healthcare manager focused on high-impact life science innovation across private and public markets. Founded in 2013 by Frank Yu, Co-Chief Executive Officer and Co-Chief Investment Officer, the firm manages assets from offices in New York and Hong Kong. Our mission is to generate superior risk-adjusted returns for investors while seeking to address unmet medical needs. We aim to achieve this by blending deep scientific and clinical research with financial and capital markets expertise.

COM:ALLY-BRIDGE

Ally Bridge Group

Analysis Not Available